scholarly journals Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 Countries

2022 ◽  
Author(s):  
Angelo Antonini ◽  
Rajesh Pahwa ◽  
Per Odin ◽  
Tove Henriksen ◽  
Michael J. Soileau ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Psychometric Properties ◽  
Real World ◽  
G7 Countries ◽  
Clinical Indicators ◽  
Advanced Parkinson’S Disease ◽  
Real World Evidence

Thiazolidinedione use is associated with reduced risk of Parkinson’s disease in patients with diabetes: a meta-analysis of real-world evidence

2020 ◽  
Vol 41 (12) ◽  
pp. 3697-3703
Author(s):  
Salman Hussain ◽  
Ambrish Singh ◽  
Harveen Baxi ◽  
Bruce Taylor ◽  
John Burgess ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Real World ◽  
Meta Analysis ◽  
Real World Evidence ◽  
Patients With Diabetes ◽  
Reduced Risk

Combining dopamine agonists of different dopamine receptor profiles in advanced Parkinson's disease

2004 ◽  
Vol 31 (S 1) ◽  
Author(s):  
F Sixel-Döring ◽  
M Rausch-Hertel ◽  
H Klinke ◽  
C Trenkwalder
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Dopamine Receptor ◽  
Dopamine Agonists ◽  
Advanced Parkinson’S Disease
Sign in / Sign up

Export Citation Format

Share Document